LEVOPHED Side Effects

6694423-8 | Blood Pressure Decreased, Blood Pressure Increased, Cardiac Arrest, Convulsion, Dialysis, Overdose, Pallor, Peripheral Coldness, Pulse Absent
on Apr 12, 2010 Male patient from UNITED STATES , 25 years of age, weighting 96.78 lb, was diagnosed with blood pressure abnormal and was treated with Levophed (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, blood pressure increased, cardiac arrest (What is cardiac arrest?), convulsion, dialysis (What is dialysis?), overdose, pallor, peripheral coldness, pulse absent. Levophed dosage: See Image. During the same period patient was treated with DOPAMINE HYDROCHLORIDE INJECTION (DOPAMINE HYDROCHLORIDE) (View Dopamine Hydrochloride Injection (dopamine Hydrochloride) Review and Dopamine Hydrochloride Injection (dopamine Hydrochloride) Label ), PHENYLEPHRINE HCL INJ USP 1% (PHENYLEPHRINE) (View Phenylephrine Hcl Inj Usp 1% (phenylephrine) Review and Phenylephrine Hcl Inj Usp 1% (phenylephrine) Label ), (VASOPRESSIN) (View (vasopressin) Review and (vasopressin) Label ), DOBUTAMINE IN 5% DEXTROSE INJ USP (DOBUTAMINE HYDROCHLORIDE) (View Dobutamine In 5% Dextrose Inj Usp (dobutamine Hydrochloride) Review and Dobutamine In 5% Dextrose Inj Usp (dobutamine Hydrochloride) Label ), 5% DEXTROSE INJ, USP 250ML (DEXTROSE) (View 5% Dextrose Inj, Usp 250ml (dextrose) Review and 5% Dextrose Inj, Usp 250ml (dextrose) Label ).

6637632-6 | Cardiac Arrest, Cerebral Haemorrhage, Convulsion, Dialysis, Overdose, Pallor, Pyrexia, Renal Failure, Sepsis
Patient was taking Levophed (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cerebral haemorrhage, convulsion, dialysis (What is dialysis?), overdose, pallor, pyrexia, renal failure, sepsis (What is sepsis?) on Mar 03, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, weighting 96.78 lb, was diagnosed with blood pressure decreased and. Levophed dosage: 4mg In 250ml D5w, Continuous, 32mg In 250ml D5w, Continuous. During the same period patient was treated with DEXTROSE (View Dextrose Review and Dextrose Label ).

6177121-9 | Cellulitis, Erythema, Infusion Site Extravasation, Oedema Peripheral, Paraesthesia, Skin Necrosis, Thermal Burn, Wound
Adverse event was reported on Apr 30, 2009 by a Male patient taking Levophed (View Usage) (Dosage: ) was diagnosed with hypotension, post procedural haemorrhage and. Location: UNITED STATES , 45 years of age, After Levophed was administered, patient had the following side effects: cellulitis (What is cellulitis?), erythema, infusion site extravasation, oedema peripheral, paraesthesia, skin necrosis, thermal burn, wound (What is wound?). During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), MILRINONE (View Milrinone Review and Milrinone Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), COLACE (View Colace Review and Colace Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), IRON SUPPLEMENT (View Iron Supplement Review and Iron Supplement Label ), RENAL DIALYSIS (View Renal Dialysis Review and Renal Dialysis Label ). Patient was hospitalized.

5968013-6 | Injection Site Extravasation, Injection Site Necrosis
on Nov 21, 2008 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with hypotension and was treated with Levophed (View Usage). Patient experienced the following unwanted or unexpected effects: injection site extravasation, injection site necrosis. Levophed dosage: .


5734346-1 | Ventricular Tachycardia
on May 08, 2008 Female patient from UNITED STATES , 79 years of age, weighting 110.2 lb, was treated with Levophed (View Usage). Patient had the following side effects: ventricular tachycardia. Levophed dosage: .

5688271-5 | Colectomy, Gangrene, Hypotension, Ileostomy, Ischaemia, Leg Amputation, Unresponsive To Stimuli
Patient was taking Levophed (View Usage). After Levophed was administered, patient had the following side effects: colectomy, gangrene, hypotension, ileostomy, ischaemia, leg amputation, unresponsive to stimuli on Mar 28, 2008 from UNITED STATES Additional patient health information: Female patient , 32 years of age, weighting 172.0 lb, was diagnosed with hypotension, sepsis (What is sepsis?) and. Levophed dosage: Titrated To Bp Iv Drip. During the same period patient was treated with DOPAMINE HCL (Titrated To Bp Iv Drip) (View Dopamine Hcl Review and Dopamine Hcl Label ), ZOSYN (View Zosyn Review and Zosyn Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), NEPHROVITE (View Nephrovite Review and Nephrovite Label ), CUBICIN (View Cubicin Review and Cubicin Label ).

5152125-3 | Graft Complication, Infusion Site Reaction, Oedema Peripheral
Adverse event was reported on Nov 14, 2006 by a Male patient taking Levophed (View Usage) (Dosage: Titrate Iv Drip) was diagnosed with blood pressure systolic decreased and. Location: UNITED STATES , 51 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: graft complication, infusion site reaction, oedema peripheral. Patient was hospitalized.

5097304-9 | Acidosis, Acinetobacter Infection, Bronchopneumonia, Dry Gangrene, Electromechanical Dissociation, Enterobacter Infection, Hyperkalaemia, Refusal Of Treatment By Relative, Renal Failure Acute
on Aug 23, 2006 Male patient from MALAYSIA , 63 years of age, was treated with Levophed (View Usage). Patient had the following side effects: acidosis, acinetobacter infection, bronchopneumonia, dry gangrene, electromechanical dissociation, enterobacter infection, hyperkalaemia, refusal of treatment by relative, renal failure acute. Levophed dosage: Continuous, Intravenous. During the same period patient was treated with TIFACOGIN SOLUTION FOR INFUSION (View Tifacogin Solution For Infusion Review and Tifacogin Solution For Infusion Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).